UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UNCY is currently covered by 2 analysts with an average price target of $-0.67. This is a potential upside of $-5.67 (-113.4%) from yesterday's end of day stock price of $5.

Unicycive Therapeutics's activity chart (see below) currently has 36 price targets and 39 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.1% with an average time for these price targets to be met of 254 days.

Highest price target for UNCY is $7.5, Lowest price target is $3, average price target is $5.25.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 11-Apr-2025. First documented stock forecast 09-Aug-2021.

Best performing analysts who are covering UNCY - Unicycive Therapeutics:

Elemer Piros Jason Mccarthy Bruce Jackson Ed Arce

Currently out of the existing stock ratings of UNCY, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$7.5

$2.79 (59.24%)

$7.5

6 months 9 days ago
(11-Apr-2025)

19/23 (82.61%)

$2.02 (36.86%)

103

Buy

$3

$-1.71 (-36.31%)

$3

10 months 28 days ago
(22-Nov-2024)

7/9 (77.78%)

$-2.3 (-43.40%)

162

Buy

$5

$0.29 (6.16%)

$5

2 years 3 months 20 days ago
(30-Jun-2023)

4/4 (100%)

$-7.8 (-60.94%)

192

Buy

$6

$1.29 (27.39%)

$3

2 years 7 months 11 days ago
(09-Mar-2023)

2/2 (100%)

$-14.6 (-70.87%)

559

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 254 days on average for the stock forecasts to be realized with a an average price target met ratio 90.1

Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the current lower performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Elemer Piros has 6 price targets and 6 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Ed Arce with highest potential upside - $2.79

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Bruce Jackson with lowest potential downside - -$1.71

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?